Bioactive coatings for coronary stents: Modulation of cell proliferation by controlled release of anti-proliferative drugs
Source abstract
Abstract
Drug eluting coronary stents coated with a bioactive and biostable polymer system (THBA70), based on acrylate copolymers bearing a salicylic acid derivative as side substituent, were evaluated. The microstructural architecture of the copolymer THBA70 comprises a random copolymer of a methacrylate derivative from triflusal (4-trifluoromethyl salicylic acid) with 45 mol% of THEMA (2-methacryloyloxyethyl [2-(acetyloxy)-4-(trifluoromethyl)] benzoate), which makes the system anti-thrombogenic with good adhesion to the surface of metallic stents. The bioactive coating prevented thrombosis, an adverse effect associated with the implantation of drug-eluting stents. The in vitro drug delivery of drug-eluting stents under dynamic conditions indicated excellent controlled drug release. The THBA70 films loaded with relatively low concentrations of taxol or simvastatin in contact with fibroblasts produced inhibition of cell proliferation with a dose-dependent bioactivity.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Coronary Interventions and Diagnostics · Cardiac Valve Diseases and Treatments · Antiplatelet Therapy and Cardiovascular Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biomaterials Group, Polymeric Nanomaterials and Biomaterials Department, Institute of Polymer Science and Technology, CSIC, Madrid, Spain
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Zaragoza, Spain
Associate Unit CSIC-Avila’s Provincial Hospital, Ávila, Spain
LVD Biotech, Barcelona, Spain
References (30)
Show source-provided references
1. 10.1016/j.amjcard.2006.09.10710.1016/j.amjcard.2006.09.107 ↗
2. 10.1016/j.jacc.2010.06.00710.1016/j.jacc.2010.06.007 ↗
3. 10.1177/088391150505166110.1177/0883911505051661 ↗
4. 10.1177/088391150910427310.1177/0883911509104273 ↗
5. 10.1001/jama.295.11.126410.1001/jama.295.11.1264 ↗
6. 10.1001/jama.295.11.125310.1001/jama.295.11.1253 ↗
7. 10.2165/11316500-000000000-0000010.2165/11316500-000000000-00000 ↗
8. 10.1002/ccd.2253310.1002/ccd.22533 ↗
9. 10.1093/eurheartj/ehm40210.1093/eurheartj/ehm402 ↗
10. 10.1038/nrcardio.2010.1410.1038/nrcardio.2010.14 ↗
11. 10.1002/jbm.b.3159210.1002/jbm.b.31592 ↗
12. 10.1177/088391151039145210.1177/0883911510391452 ↗
13. 10.1016/j.jacc.2010.06.00810.1016/j.jacc.2010.06.008 ↗
14. 10.1016/j.medengphy.2010.10.00910.1016/j.medengphy.2010.10.009 ↗
15. 10.1161/CIRCULATIONAHA.106.66680010.1161/CIRCULATIONAHA.106.666800 ↗
16. 10.1111/j.1540-8183.2009.00489.x10.1111/j.1540-8183.2009.00489.x ↗
17. 10.1016/j.biomaterials.2010.01.14710.1016/j.biomaterials.2010.01.147 ↗
18. 10.1021/bm100801k10.1021/bm100801k ↗
19. 10.2165/00003495-199855060-0001110.2165/00003495-199855060-00011 ↗
20. 10.1161/01.CIR.0000140694.67251.9C10.1161/01.CIR.0000140694.67251.9C ↗
21. 10.1016/S0735-1097(99)00526-410.1016/S0735-1097(99)00526-4 ↗
22. 10.1161/01.CIR.0000047700.58683.A110.1161/01.CIR.0000047700.58683.A1 ↗
23. 10.1023/A:100898530282610.1023/A:1008985302826 ↗
24. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
25. 10.2165/00003088-199732050-0000510.2165/00003088-199732050-00005 ↗
26. 10.1016/j.cardiores.2003.11.03210.1016/j.cardiores.2003.11.032 ↗
27. 10.2174/156800604358613410.2174/1568006043586134 ↗
28. 10.1161/01.CIR.0000022843.76104.0110.1161/01.CIR.0000022843.76104.01 ↗
29. 10.3892/ijmm_0000052010.3892/ijmm_00000520 ↗
30. 10.1152/ajplung.00491.200510.1152/ajplung.00491.2005 ↗